{"effective_time":"20171205","id":"ab3616d4-5124-4fb6-8f8e-8d408bcdd7fe","openfda":{},"package_label_principal_display_panel":["PRINCIPAL DISPLAY PANEL NDC 0173-0881-01 Nucala ® (mepolizumab) for Injection 100 mg/vial Rx Only For subcutaneous injection after reconstitution. Single-use vial. Discard unused portion. Contents: Each vial delivers mepolizumab 100 mg, polysorbate 80 (0.67 mg), sodium phosphate dibasic heptahydrate (7.14 mg), and sucrose (160 mg). After reconstitution with 1.2 mL of Sterile Water for Injection, USP, the reconstituted solution concentration is 100 mg/mL and delivers 1 mL. No preservative. No U.S. standard of potency. 1 vial Do not accept if plastic overseal is missing or not securely fitted. ©2016 the GSK group of companies 10000000141958 Rev. 6/16 Nucala 100 mg per vial carton"],"set_id":"4b7574ab-c677-4206-bdf3-9ced88fb09ff","spl_product_data_elements":["Nucala mepolizumab MEPOLIZUMAB MEPOLIZUMAB POLYSORBATE 80 SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE SUCROSE"],"version":"3"}